Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome

Transplantation

Volumn 90, Issue 5, 2010, Pages 540-546

  Bhorade, Sangeeta M ^a   Chen, Hong ^a   Molinero, Luciana ^a   Liao, Chuanhong ^a   Garrity, Edward R ^a   Vigneswaran, Wickii T ^a   Shilling, Rebecca ^a   Sperling, Anne ^a   Chong, Anita ^a   Alegre, Maria Luisa ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

BOS; FoxP3; Lung transplantation; Regulatory T cells; Tolerance

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MACROPHAGE DERIVED CHEMOKINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CD4 LYMPHOCYTE PERCENTAGE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; LUNG DISEASE; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; ADOLESCENT; AGED; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEIVER OPERATING CHARACTERISTIC; REPERFUSION INJURY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHIOLITIS OBLITERANS; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPERFUSION INJURY; ROC CURVE; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; YOUNG ADULT;

EID: 77957266090     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e8dabe     Document Type: Article

References (29)

1. Tilney NL, Whitley WD, Diamond JR, et al. Chronic rejection\An undefined conundrum. Transplantation 1991; 52: 389.
2. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am JRespir Crit Care Med 2002; 166: 440.
3. Burlingham WJ, Love RB, Jankowska-GanE, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 3498.
4. + regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant 2006; 6: 1799.
5. Bobadilla JL, Love RB, Jankowska-Gan E, et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008; 177: 660.
6. + regulatory T cells through CTLA-4 signaling. J Immunol 2006; 177: 5631.
7. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20.
8. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new fork-head/winged-helix protein, scurfin, results in the fatal lymphoprolif-erative disorder of the scurfy mouse. Nat Genet 2001; 27: 68.
9. + regulatory T cells. Nat Immunol 2003; 4:330.
10. + T regulatory cells. Nat Immunol 2003; 4: 337.
11. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282.
12. Chen L, Ahmed EM, Wang T, et al. TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol 2009; 182: 6217.
13. Slebos DJ, Kauffman HF, Koeter GH, et al. Airway cellular response to two different immunosuppressive regimens in lung transplant recipients. Clin Transplant 2005; 19: 243.
14. + T cells in the peripheral blood of lung transplant recipients: Correlation with transplant outcome. Transplantation 2004; 77: 762.
15. Mamessier E, Lorec AM, Thomas P, et al. T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 2007; 84: 908.
16. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201: 1037.
17. Meng L, Wu Z, Wang Y, et al. Differential impact of CD154 costimu-lation blockade on alloreactive effector and regulatory T cells in murine renal transplant recipients. Transplantation 2008; 85: 1332.
18. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002; 38: 881.
19. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasma-cytoid dendritic cells mediate tolerance to vascularized grafts. NatIm-munol2006; 7: 652.
20. Sather BD, Treuting P, Perdue N, et al. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 2007; 204: 1335.
21. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942.
22. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006; 97: 1139.
23. Mailloux AW, Young MR. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenviron-ment. J Immunol 2009; 182: 2753.
24. Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol 2002; 22: 105.
25. Workman CJ, Szymczak-Workman AL, Collison LW, et al. The development and function of regulatory T cells. CellMolLife Sci 2009; 24:24.
26. Neujahr DC, Cardona AC, Ulukpo O, et al. Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 2009; 88: 521.
27. Brown K, Wong W. Diagnostic value of regulatory T cells: A new facet of a much studied cell population. Transplantation 2008; 86: 1485.
28. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. NEngl J Med 2005; 353: 2342.
29. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297.